Manidipine Hydrochloride/Delapril Hydrochloride

盐酸马尼地平/盐酸地拉普利

Report date: 2023/04/21 13:58:36

Base Information

Drug NameManidipine Hydrochloride/Delapril Hydrochloride
Drug Alias Name地拉普利马尼地平片delapril hydrochloride and manidipine hydrochloride地拉普利+马尼地平manidipine hydrochloride and delapril hydrochlorideDelapril Hydrochloride/Manidipine Hydrochloride +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEUMainland China
CombinationsYes Manidipine HydrochlorideDelapril Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Farmaceutici SPA
Inactive CompaniesSichuan Baili Pharmaceutical Co Ltd
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BB
Related LinksN/A